Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | GPR52 | Q9Y2T5 | 7/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | GRM5 | P41594 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | ACP3 | P15309 | 1/20 | 0.40 |
| ▸ | PDE5A | O76074 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4551657 | 0.80 | LTA4H (0.57) | LTA4HGPR52CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL1659458 | 0.78 | HDAC1 (0.50) | LTA4HGPR52CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL3237564 | 0.71 | TAAR1 (0.64) | LTA4HIDO1DAOACP3TAAR1 | |
| SCHEMBL1199371 | 0.69 | ALDH1A1 (0.64) | LTA4HGPR52 | |
| SCHEMBL14108792 | 0.68 | GPR52 (0.51) | LTA4HGPR52CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL1758495 | 0.67 | TAAR1 (0.59) | IDO1DAOACP3TAAR1 | |
| SCHEMBL3467590 | 0.67 | LMNA (0.61) | LTA4HGPR52CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL14108814 | 0.67 | ALDH1A1 (0.53) | GPR52 | |
| SCHEMBL14109116 | 0.67 | GPR52 (0.61) | LTA4HGPR52CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL30370514 | 0.66 | TAAR1 (0.58) | LTA4HIDO1DAOACP3TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2307394-A2 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Amorepacific Corporation (KR) | 2011-04-13 | — | — | EP | disclosed |
| WO-2010002209-A2 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | AMOREPACIFIC CORPORATION (KR) | 2010-01-07 | — | — | WO | disclosed |